173 related articles for article (PubMed ID: 34428218)
41. Evaluation of local, regional and abscopal effects of Boron Neutron Capture Therapy (BNCT) combined with immunotherapy in an ectopic colon cancer model.
Trivillin VA; Langle YV; Palmieri MA; Pozzi ECC; Thorp SI; Benitez Frydryk DN; Garabalino MA; Monti Hughes A; Curotto PM; Colombo LL; Santa Cruz IS; Ramos PS; Itoiz ME; Argüelles C; Eiján AM; Schwint AE
Br J Radiol; 2021 Dec; 94(1128):20210593. PubMed ID: 34520668
[TBL] [Abstract][Full Text] [Related]
42. Abscopal Regressions of Lymphoma After Involved-Site Radiation Therapy Confirmed by Positron Emission Tomography.
MacManus MP; Hofman MS; Hicks RJ; Campbell BA; Wirth A; Seymour JF; Haynes N; Burbury K
Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):204-211. PubMed ID: 32151671
[TBL] [Abstract][Full Text] [Related]
43. Abscopal Effect of Radiotherapy in the Immunotherapy Era: Systematic Review of Reported Cases.
Dagoglu N; Karaman S; Caglar HB; Oral EN
Cureus; 2019 Feb; 11(2):e4103. PubMed ID: 31057997
[TBL] [Abstract][Full Text] [Related]
44. Radiotherapy and Immunotherapy for Cancer: From "Systemic" to "Multisite".
Arina A; Gutiontov SI; Weichselbaum RR
Clin Cancer Res; 2020 Jun; 26(12):2777-2782. PubMed ID: 32047000
[TBL] [Abstract][Full Text] [Related]
45. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors.
Liu Y; Dong Y; Kong L; Shi F; Zhu H; Yu J
J Hematol Oncol; 2018 Aug; 11(1):104. PubMed ID: 30115069
[TBL] [Abstract][Full Text] [Related]
46. Pretreatment CT-Based Radiomics Signature as a Potential Imaging Biomarker for Predicting the Expression of PD-L1 and CD8+TILs in ESCC.
Wen Q; Yang Z; Zhu J; Qiu Q; Dai H; Feng A; Xing L
Onco Targets Ther; 2020; 13():12003-12013. PubMed ID: 33244242
[TBL] [Abstract][Full Text] [Related]
47. Abscopal Effect Following Immunotherapy and Combined Stereotactic Body Radiation Therapy in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma: A Report of Two Cases and Literature Review.
Choi JS; Sansoni ER; Lovin BD; Lindquist NR; Phan J; Mayo LL; Ferrarotto R; Su SY
Ann Otol Rhinol Laryngol; 2020 May; 129(5):517-522. PubMed ID: 31875405
[TBL] [Abstract][Full Text] [Related]
48. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [
Zhao X; Zhao Y; Zhang J; Zhang Z; Liu L; Zhao X
EJNMMI Res; 2023 Jan; 13(1):4. PubMed ID: 36682020
[TBL] [Abstract][Full Text] [Related]
49. Analysis of the Abscopal Effect With Anti-PD1 Therapy in Patients With Metastatic Solid Tumors.
Ribeiro Gomes J; Schmerling RA; Haddad CK; Racy DJ; Ferrigno R; Gil E; Zanuncio P; Buzaid AC
J Immunother; 2016; 39(9):367-372. PubMed ID: 27741091
[TBL] [Abstract][Full Text] [Related]
50. NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8
Walker JM; Rolig AS; Charych DH; Hoch U; Kasiewicz MJ; Rose DC; McNamara MJ; Hilgart-Martiszus IF; Redmond WL
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457127
[TBL] [Abstract][Full Text] [Related]
51. Abscopal effect in the radio and immunotherapy.
Pevzner AM; Tsyganov MM; Ibragimova MK; Litvyakov NV
Radiat Oncol J; 2021 Dec; 39(4):247-253. PubMed ID: 34986545
[TBL] [Abstract][Full Text] [Related]
52. Cisplatin and Albumin-Based Gold-Cisplatin Nanoparticles Enhance Ablative Radiation Therapy-Induced Antitumor Immunity in Local and Distant Tumor Microenvironment.
Chen JL; Yang SJ; Pan CK; Lin LC; Tsai CY; Wang CH; Huang YS; Lin YL; Kuo SH; Shieh MJ
Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1135-1149. PubMed ID: 36792014
[TBL] [Abstract][Full Text] [Related]
53. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
[TBL] [Abstract][Full Text] [Related]
54. A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
Yang H; Wang L; Shao G; Dong B; Wang F; Wei Y; Li P; Chen H; Chen W; Zheng Y; He Y; Zhao Y; Du X; Sun X; Wang Z; Wang Y; Zhou X; Lai X; Feng W; Shen L; Qiu G; Ji Y; Chen J; Jiang Y; Liu J; Zeng J; Wang C; Zhao Q; Yang X; Hu X; Ma H; Chen Q; Chen M; Jiang H; Xu Y
Front Oncol; 2022; 12():967360. PubMed ID: 35982975
[TBL] [Abstract][Full Text] [Related]
55. CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy.
Yang F; Zhang J; Zhou L; Xia W; Zhang R; Wei H; Feng J; Zhao X; Jian J; Gao X; Yuan S
Eur Radiol; 2022 Mar; 32(3):1538-1547. PubMed ID: 34564744
[TBL] [Abstract][Full Text] [Related]
56. Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects.
Tubin S; Popper HH; Brcic L
Radiat Oncol; 2019 Jan; 14(1):21. PubMed ID: 30696472
[TBL] [Abstract][Full Text] [Related]
57. Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response.
Zhang X; Niedermann G
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):63-73. PubMed ID: 29534901
[TBL] [Abstract][Full Text] [Related]
58. [Abscopal effect: Myth or reality?].
Mirjolet C; Truc G
Cancer Radiother; 2021 Oct; 25(6-7):533-536. PubMed ID: 34462213
[TBL] [Abstract][Full Text] [Related]
59. Reduction of Lung Metastases in a Mouse Osteosarcoma Model Treated With Carbon Ions and Immune Checkpoint Inhibitors.
Helm A; Tinganelli W; Simoniello P; Kurosawa F; Fournier C; Shimokawa T; Durante M
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):594-602. PubMed ID: 32980497
[TBL] [Abstract][Full Text] [Related]
60. Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects.
Blanquicett C; Saif MW; Buchsbaum DJ; Eloubeidi M; Vickers SM; Chhieng DC; Carpenter MD; Sellers JC; Russo S; Diasio RB; Johnson MR
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8773-81. PubMed ID: 16361565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
